GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » YoY EPS Growth

Oxurion NV (FRA:TG40) YoY EPS Growth : 98.77% (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Oxurion NV's YoY EPS Growth for the quarter that ended in Jun. 2024 was 98.77%.

Oxurion NV's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was €-2.47.

Oxurion NV YoY EPS Growth Historical Data

The historical data trend for Oxurion NV's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV YoY EPS Growth Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.57 45.95 -5.25 51.95 97.30

Oxurion NV Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.81 88.04 93.75 94.28 98.77

Oxurion NV YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Oxurion NV's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-100--3700)/ | -3700 |
=97.30 %

Oxurion NV's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(-2.466--200)/ | -200 |
=98.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxurion NV YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Oxurion NV's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » YoY EPS Growth
Comparable Companies
XBRU:BIOS VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR OCSE:GMAB XKRX:196170 PCVX SHSE:603392 BMRN INCY
Traded in Other Exchanges
OXUR:Belgium
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Website
https://www.oxurion.com
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines